1. Market Research
  2. > Healthcare Market Trends
  3. > Diagnostics

Medical Diagnostics Industry Overview: Latest Market Reports & Studies

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
19 votes

Global Diagnostics Industry

The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy. The section is part of the wider healthcare industry.

The market can be broadly divided into:

  1. In vitro diagnostics (IVD), which refers to testing samples of blood, tissue, for example electrocardiography; and
  2. Diagnostic imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).

Leading Market Segment

The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.

Blood grouping reagent Export

Diagnostics Industry Regional Market Share

The In Vitro Diagnostic market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.

In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.

Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.

Top 3 Medical Diagnostics Players

Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.

Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.

In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.

Read more »

24/7 Customer Support

Talk to Sam

+44 208 068 8943

1-10 of about 1600 reports

Global Diagnostics and Laboratory Industry

  • August 2017
    113 pages
  • Diagnostics  



  • World  

    North America  

    United States  

View report >

Diagnostics Markets in the US

  • November 2017
    7 pages
  • United States  

    North America  

View report >

Diagnostics Industry in Europe

  • August 2017
    38 pages
  • Diagnostics  

    Antibiotic Resi...  

  • Europe  

View report >

Diagnostics Industry in Japan

  • January 2017
    20 pages
  • Autoimmune Dise...  

  • Japan  


View report >

The future of the Diagnostics Industry in the UK and the US

  • October 2017
    13 pages
  • Diagnostics  

  • United Kingdom  

    United States  

View report >

Diagnostics Industry in Canada

  • June 2017
    5 pages
  • Diagnostics  


  • Canada  

    North America  

View report >

Diagnostics Industry in China - Forecast

  • July 2016
    41 pages
  • Diagnostic Reag...  



  • China  

View report >

Diagnostics Industry in South Africa

  • September 2016
    8 pages
  • Diagnostics  

  • South Africa  

    United States  

View report >

Diagnostics Industry in Australia

  • May 2015
    13 pages
  • Diagnostics  


  • Australia  

View report >

Infectious Disease Statistics in South Africa

  • December 2017
    3 pages
  • Infectious Dise...  



  • South Africa  


View report >

About 7700 reports

Purchase Reports From Reputable Market Research Publishers
(From € 135 - € 32727)

Cellular Health Screening/Health Testing Market by Type, Multitest, Sample, Collection Site, and Region - Global Forecast to 2022

Cellular Health Screening/Health Testing Market: Global Forecast until 2022

  • € 8452
  • Industry report
  • July 2017
  • by MarketsandMarkets

“Cellular health screening market projected to grow at a CAGR of 10.0% from 2017 to 2022.”The global cellular health screening market is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion ...

Cancer Biomarkers Market: Global Forecast until 2022 € 6384 October 2017

Tissue Diagnostics Market: Global Forecast until 2022 € 5045 November 2017

Life Science Instrumentation Market: Global Forecast un ... € 5045 September 2017

Microbial Identification Market: Global Forecast until ... € 5045 September 2017

Dental Lab Market: Global Forecast until 2022 € 5045 September 2017

Laboratory Informatics Market: Global Forecast until 20 ... € 5045 September 2017

Biopsy Devices Market: Global Forecast until 2022 € 5045 August 2017

Preimplantation Genetic Testing Market: Forecast until ... € 5045 July 2017

Digital PCR and Real-time PCR Market: Forecast until 20 ... € 5045 June 2017

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.